New capillary electrophoretic method for on‐line screenings of drug metabolism mediated by cytochrome P450 enzymes
Authors:
- 28 May 2013
- journal article
- research article
- Published by Wiley in Electrophoresis
- Vol. 34 (18) , 2705-2711
Abstract
A new method for the determination of kinetic and inhibition parameters of cytochromes P450 reactions by means of on-line CE was developed. It is based on transverse diffusion of laminar flow profiles methodology introduced by Krylov et al. that injection procedure was modified. The solutions of an enzyme and its substrates are injected by hydrodynamic pressure as a series of repeated consecutive plugs. Proposed injection of three plugs of enzyme surrounded with plugs of substrates represents a certain trade-off to obtain the reaction mixture with the satisfying homogeneity by the short-injection procedure as possible. Mathematical modeling confirmed the assumption of a consistent distribution of reactants in the final reaction mixture. Kinetic and inhibition studies of cytochrome P450 isoform 2C9's reaction with diclofenac as a probe substrate and sulfaphenazole as a probe inhibitor were conducted in order to prove the practical applicability of the proposed method for on-line screenings of drug metabolism mediated by cytochrome P450 enzymes. As a result, an apparent Michaelis constant of 2.66 ± 0.18 μM, apparent maximum reaction velocity of 7.91 ± 0.22 nmol min−1 nmol−1, Hill coefficient of 1.59 ± 0.16, half maximal inhibitory concentration of 0.94 ± 0.04 μM and apparent inhibition constant of 0.39 ± 0.07 μM were determined. All these values are in agreement with literature data obtained using different techniques. In addition, less than 30 nL of cytochrome P450 2C9 solution was consumed per analysis in the kinetic and inhibition studies using this method.Keywords
This publication has 30 references indexed in Scilit:
- Application of carbon nanotubes for in‐capillary incubations with cytochrome P450 enzymesElectrophoresis, 2010
- Study of atypical kinetic behaviour of cytochrome P450 2C9 isoform with diclofenac at low substrate concentrations by sweeping‐MEKC combinationJournal of Separation Science, 2010
- Development and full validation of six inhibition assays for five major cytochrome P450 enzymes in human liver microsomes using an automated 96-well microplate incubation format and LC–MS/MS analysisJournal of Pharmaceutical and Biomedical Analysis, 2007
- Study of recombinant cytochrome P450 2C9 activity with diclofenac by MEKCElectrophoresis, 2007
- Screening of drug metabolism by CEElectrophoresis, 2006
- Transverse Diffusion of Laminar Flow Profiles To Produce Capillary NanoreactorsAnalytical Chemistry, 2005
- DEVELOPMENT AND VALIDATION OF A HIGH-THROUGHPUT RADIOMETRIC CYP2C9 INHIBITION ASSAY USING TRITIATED DICLOFENACDrug Metabolism and Disposition, 2005
- Human Drug Metabolism and the Cytochromes P450: Application and Relevance of In Vitro ModelsThe Journal of Clinical Pharmacology, 2001
- The History of Poiseuille's LawAnnual Review of Fluid Mechanics, 1993
- Cytochrome P450TB (CYP2C): A major monooxygenase catalyzing diclofenac 4′-hydroxylation in human liverLife Sciences, 1993